Navigate Up

Neuroendocrine Cancer Research at UPMC

UPMC and its academic partner, the University of Pittsburgh, are world-renowned for providing leading-edge research designed to find the latest advances in cancer prevention, detection, diagnosis, and treatment.

A clinical trial is a way for physicians to test a new treatment for its safety and effectiveness. Participants are typically patients who have the disease. Participants must be informed of the possible risks and benefits associated with the clinical trial, and are required to follow all treatment protocol.

Neuroendocrine Cancer Clinical Trials at UPMC

Some of our current research and clinical trial activities in the field of neuroendocrine cancer treatment include:

Pathfinder NIH Trial – This novel investigation provides instant feedback to surgeons and helps them make decisions during liver surgery for neuroendocrine cancer.

Tissue/Serum/Urine Bank – This effort stores samples of tissue, serum, and urine from neuroendocrine cancer patients who are seen in the clinic or in the operating room. These samples are catalogued and stored for molecular analysis, and for collaboration with other research initiatives throughout UPMC and the University of Pittsburgh School of Medicine

Regional chemoembolization – A therapy for inoperable liver tumors, chemoembolization remains an important part the Neuroendocrine Cancer Center's treatment approach. With over 300 treatments of chemoembolization administered yearly, our center is widely recognized as a leader in the field.

Yttrium 90 (Y90) – This is an evolving therapy for inoperable neuroendocrine tumors. Although the use of Y90 for neuroendocrine cancer is limited, this therapy represents an exciting area for upcoming investigation.

Learn More About Neuroendocrine Cancer Research

To find out more about neuroendocrine cancer research at UPMC, including whether you may qualify to participate in a clinical trial for neuroendocrine cancer treatment, please call our office at 412-692-2001, or visit Pitt's Office of Clinical Research.

Contact Us

UPMC Neuroendocrine Cancer Treatment Center

UPMC Montefiore
3459 Fifth Ave.
Pittsburgh, PA 15213-2582

Schedule an appointment
at 412-692-2001 or request an appointment online.

UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences | Supplemental content provided by Healthwise, Incorporated. To learn more, visit

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, gender identity, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

Pittsburgh, PA, USA |